Intelligent Bio Solutions
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	6/30/2022	6/30/2023	6/30/2024	6/30/2026	6/30/2027
Revenue % change YoY	$0 N/A	$1.25M 0%	$3.11M 147.58%	Avg: $26.29M Low: $26.29M High: $26.29M avg. 744.85%	Avg: $14.65M Low: $14.65M High: $14.65M avg. -44.27%
Net Income % change YoY	$-8.30M N/A	$-10.63M -27.99%	$-10.15M 4.46%	Avg: $2.08M Low: $351.60K High: $351.60K avg. 120.57%	Avg: $-9.40M Low: $-9.40M High: $-9.40M avg. -549.90%
EBITDA % change YoY	$-8.32M N/A	$-9.47M -13.84%	$-8.81M 7.00%	Avg: $-5.25M Low: $-5.25M High: $-5.25M avg. 40.32%	Avg: $-2.93M Low: $-2.93M High: $-2.93M avg. 44.27%
EPS % change YoY	-$11.33 N/A	-$10.58 6.61%	-$6.38 39.69%	Avg: $0.35 Low: $0.35 High: $0.35 avg. 105.48%	Avg: -$9.36 Low: -$9.36 High: -$9.36 avg. -2774.28%
Operating Expenses % change YoY	$8.33M N/A	$8.76M 5.11%	$11.70M 33.61%	Avg: $121.59M Low: $121.59M High: $121.59M avg. 938.49%	Avg: $67.76M Low: $67.76M High: $67.76M avg. -44.27%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -214.66% in 2026-2027.

We have gathered data from 1 analysts. Their low estimate is 351.60K, average is 2.08M and high is 351.60K.

Wall Street analysts forecast annual average revenue growth of 350.29% in 2026-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $26.29M, average is $26.29M and high is $26.29M.

Wall Street analysts forecast annual average earnings growth of -1334.39% in 2026-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is $0.35, average is $0.35 and high is $0.35.